exfoliative erythroderma

DBCOND0021260Immune System DiseasesSkin and Subcutaneous Tissue Diseases

exfoliative erythroderma is the indication for 12 drugs in DrugBank. It is covered by 13 curated, structured indications.

Also known as
Exfoliative dermatitis
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10L26SNOMED CT123702007MedDRA10012455UMLSC0011606

What you can answer from here — as of October 04, 2026

12Indicated drugsWith each drug's targets and mechanism
Listed above
13Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
163Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for exfoliative erythroderma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In